(2S)-2-(Aminocarbonyl)-2,3-Dihydro-1H-Pyrrole-1-Carboxylic Acid 1,1-Dimethylethyl Ester

What Limits Endo:Exo Ratios in Lewis Acid-Mediated Diels-Alder Cycloadditions with This Dienophile?

The (S)-configured endocyclic ene-carbamoyl framework of the substrate acts as a moderately electron-deficient dienophile in inverse-electron-demand and normal-demand [4+2] cycloadditions, with reactivity modulated by the Lewis acid chosen. Process safety assessments mandate that cyclopentadiene, freshly cracked and titrated to a peroxide value below 5 mmol/kg (ASTM E299-17), is added dropwise to a −78 °C solution of the dihydropyrrole in dichloromethane (water content <100 ppm by Karl Fischer) containing 0.4–0.6 equivalents of boron trifluoride diethyl etherate. The molar stoichiometry most commonly employed is dihydropyrrole:diene:catalyst = 1.0:1.15:0.5. Under these conditions, the Re-face of the dienophile is shielded by the N-Boc group, and the chelation-stabilised exo approach of cyclopentadiene is disfavoured, yielding the endo-hexahydroindole-dicarboxamide cycloadduct with diastereomeric ratios of 96:4 to 98:2 as quantified by ¹H NMR (Bruker AVANCE 400 MHz, integration of bridgehead proton signals). Quenching with aqueous sodium bicarbonate and extraction into ethyl acetate, followed by silica gel chromatography (Merck 60 Å, hexane/ethyl acetate 60:40), furnishes the endo adduct in 78–84 % isolated yield. Scale-up to 500 L glass-lined reactors requires extended addition time of cyclopentadiene over 6–8 hours to control the exotherm to ≤−70 °C; failure to maintain cryogenic conditions leads to retro-cycloaddition and formation of a path-generated byproduct with m/z +42 Da relative to the target cycloadduct. The resultant chiral hexahydroindole-2-carboxamide is hydrogenated (PtO₂, 1 atm H₂, EtOH) in a subsequent step to saturate the pendant norbornene double bond, affording a constrained, non-natural amino acid surroate incorporated into peptidomimetic inhibitors of the BIR2-XIAP protein–protein interaction for apoptosis restoration in oncology candidates.

Conformationally Constrained Antiviral Protease Inhibitor Building Blocks

Introduction of the 4,5-dehydroproline amide fragment into a peptide backbone restricts the pyrrolidine ring into an envelope conformation with a C4–C5 bond length of approximately 1.34 Å and a dihedral angle N1–C2–C3–C4 close to 12°, as determined by single-crystal X-ray diffraction of related N-Boc proline analogue CSD entries. In a validated process for a hepatitis C virus NS3/4A protease inhibitor lead series, the dihydropyrrole intermediate is coupled to a tripeptide acylsulfonamide C-terminal ester using HATU (1.05 eq) and N,N-diisopropylethylamine (2.5 eq) in dimethylformamide (0.2 M peptide concentration). Coupling efficiency exceeds 97 % at 0 °C within 45 minutes (HPLC area%, C18 column, acetonitrile/0.1% TFA gradient, detection at 230 nm). The pseudoproline character of the dehydroproline amide renders the peptide bond preferentially in the trans rotamer, enhancing binding to the protease active site: cocrystal structures (PDB entry relatable to ligands containing a 2,3-dihydro-1H-pyrrole moiety) show an increase in polar contact density with the oxyanion hole relative to a saturated proline analogue. The crude peptide is deprotected via hydrogenolysis of a benzyl ester followed by TFA-mediated N-Boc removal to furnish the free amine TFA salt, purified on an octadecyl silica column (YMC-Triart Prep 120 C18, 10 μm particle size). The final active pharmaceutical ingredient intermediate is controlled for content of des-formyl impurity (limit ≤0.10 %), single unknown impurity (≤0.07 %), and total impurities (≤0.30 %), aligning with ICH Q3A thresholds for a new drug substance. LC-MS analysis (ESI+) of the API initial synthesis batch confirmed a molecular ion consistent with the target macrocyclic acylsulfonamide (M+H⁺ > 800 Da), and biacore-based inhibition constants (K_i) for genotypes 1a and 3a remained below 5 nM.

Industrial reduction of the α,β-unsaturated lactam double bond in (2S)-2-(aminocarbonyl)-2,3-dihydro-1H-pyrrole-1-carboxylic acid 1,1-dimethylethyl ester to (2S)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxamide (Boc-Pro-NH₂) represents the highest-tonnage downstream transformation across multiple contract manufacturing organisations. The reaction is executed in a 3,160 L Hastelloy C-276 high-pressure autoclave (H/D ratio 1.3:1) equipped with a gas-induction Rushton turbine impeller driven at 620–680 rpm to sustain a hydrogen gas-liquid mass transfer coefficient k_La above 0.15 s⁻¹. The vessel is charged with substrate dissolved in anhydrous tetrahydrofuran (THF, water content ≤0.03 %) at a loading of 13 % w/v, and a 5 % Pd/C catalyst (Johnson Matthey type 39, sulfided grade) is slurried at a substrate-to-catalyst weight ratio of 18:1. Hydrogen is introduced to a total pressure of 5.0 ± 0.3 bar. A carefully delineated thermal window — internal temperature held at 30 ± 2 °C — is strictly enforced; excursions beyond 42 °C trigger thermal deprotection of the N-Boc group, liberating free pyrrolidine amide that partially racemises (6–12 % ee erosion per hour at 45 °C) via deprotonation at the α-carbon. Real-time process analytics technology (ReactIR 45m, Mettler Toledo) monitors the disappearance of the ene-lactam C=C stretching band at 1648 cm⁻¹. Conversion exceeds 99.9 % after 5.5 hours. Following filtration through a 0.5 μm sintered Hastelloy cartridge to remove catalyst, the THF is distilled under reduced pressure at ≤35 °C jacket temperature and the residue crystallised from ethyl acetate/n-heptane (1:3 v/v) to deliver Boc-Pro-NH₂ with an enantiomeric excess of ≥99.7 % (Chiralpak IA-3 column, 150 mm × 4.6 mm, 3 µm, hexane/EtOH/TFA 85:15:0.1, 1.0 mL/min, 25°C, retention times: (S)-enantiomer 9.3 min, (R)-enantiomer 12.1 min). Residual palladium content, determined by ICP-OES (PerkinElmer Avio 500) after trace metal digestion, does not exceed 8 ppm, satisfying the ICH Q3D oral PDE of 100 µg/day for palladium. For DPP-4 inhibitor synthesis, this Boc-Pro-NH₂ intermediate is further dehydrated with cyanuric chloride/DMF to give (S)-1-Boc-pyrrolidine-2-carbonitrile, a process unit that is tightly controlled because exposure of the nitrile to adventitious moisture generates the corresponding amide and necessitates a purity-gating re-chromatography step incurring a yield penalty of 12–15 %.

If the Primary Amide Is Dehydrated and Converted to a Tetrazole, a Carboxylic Acid Isostere Emerges

Transformation of the aminocarbonyl side chain of the dihydropyrrole scaffold into a 1H-tetrazole provides a metabolically stable mimic of a carboxylate with a pKa near 4.8, closely approximating that of the corresponding amino acid. The established sequence involves dehydration of the amide to the nitrile using benzotriazole-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP, 1.15 eq) and diisopropylethylamine (3.0 eq) in dichloromethane at ambient temperature, achieving >95 % conversion within 2 hours (monitored by TLC, Merck silica gel 60 F₂₅₄, ethyl acetate/hexane 1:1, R_f nitrile = 0.55). The crude nitrile, without further purification, is treated with sodium azide (1.5 eq) and ammonium chloride (1.5 eq) in dimethylformamide at 90 °C for 18 hours in a sealed glass pressure tube behind a blast shield. After aqueous work-up and acidification to pH 2–3 with 2N hydrochloric acid, the tetrazole product is extracted into ethyl acetate and either crystallised from tert-butyl methyl ether or purified by flash chromatography (Biotage Sfär C18 D, acetonitrile/water 30:70 to 70:30). The combined two-step yield falls in the range of 62–71 %, with the predominant mass loss attributed to a 4.5 % formation of a dimeric byproduct elucidated by HRMS. The Boc-protected tetrazole molecule is directly employed as a building block in parallel synthesis of angiotensin II type 1 receptor modulators, wherein the dihydropyrrole ring imposes a torsion on the tetrazole that improves subtype selectivity over AT₂ receptors by a factor of 6–8 relative to a flexible valine analogue. Final APIs are isolated as hydrochloride salts with stoichiometric content controlled by argentometric titration (Merck Titriplex®) and compliant with the Ph. Eur. monograph 2.5.1.

A less volume-intense but structurally intriguing application exists in the synthesis of chiral, semicrystalline polyamides via ring-opening of the ene-lactam or through polycondensation of the N-deprotected diamide. The Boc group is cleaved with HCl/dioxane (4N, 3 hours, 25 °C) to yield the corresponding amine hydrochloride, which is neutralised in situ with triethylamine and reacted with adipoyl chloride (1.0 eq relative to amine) in a low-temperature interfacial polymerisation (dichloromethane/water, 0 °C, vigorous stirring at 1200 rpm). The resulting polymer exhibits a number-average molecular weight (M_n) of 22,000–28,000 Da (GPC, DMF/LiBr, PMMA standards, Shodex KD-804 column) and a glass transition temperature (T_g) of 147 °C by DSC (TA Instruments Q2000, 10 °C/min, second heating scan, ASTM D3418-21). The inherent chiral pyrrolidine amide repeat unit induces a strong Cotton effect in circular dichroism spectra ([θ]₂₂₂ = −18,500 deg·cm²·dmol⁻¹), and the films cast from formic acid display selective adsorption of n-hexane over cyclohexane with an ideal selectivity factor of 2.9 at 30°C. Published data for this specific configuration is limited to laboratory-scale investigations, and the oxidative instability of the residual ene moiety under prolonged thermo‑oxidative conditions (OIT ≤12 min at 180 °C per ASTM D3895-19) currently restricts melt-processing at industrial scales without an antioxidant package. Nevertheless, the material has been evaluated as a chiral stationary phase precursor in enantioselective membrane separation of protected amino alcohol racemates, achieving enantiomeric excess values of >87 % in single-stage permeation tests.

Post-deblocking regeneration of a secondary amine bifunctional organocatalyst for α-aminoxylation

When the N-Boc group is removed under acid conditions (trifluoroacetic acid:dichloromethane 1:1, 2 hours, 0 °C to room temperature) and the resulting amine is buffered to its free-base form with Amberlyst A-21 resin, the (S)-2-aminocarbonyl-2,3-dihydro-1H-pyrrole scaffold serves as an enantioselective organocatalyst for the α-aminoxylation of aldehydes with nitrosobenzene. In a validated laboratory protocol, propanal (1.0 mmol) and nitrosobenzene (0.9 mmol) are combined in chloroform (HPLC grade, amylene stabilised) at −20 °C in the presence of 10 mol% of the catalyst. After 8 hours, the reaction mixture is quenched with 1,4-dithiothreitol, and the α-aminoxylated aldehyde is reduced in situ with sodium borohydride (2.0 eq, methanol, 0 °C, 30 min) to the corresponding 1,2-diol derivative. The product is isolated by flash chromatography (ethyl acetate/hexane 50:50) in 73 % yield with enantiomeric excess of 94 % (Chiralpak AD-H, hexane/iPrOH 90:10). The catalytic cycle proceeds via transient formation of an enamine intermediate between the catalyst’s secondary amine and the aldehyde; the enamide carbonyl oxygen hydrogen-bonds with the incoming nitroso electrophile, directing attack to the Si-face. The chemoselectivity for O‑attack on the α-position, as opposed to N‑attack, remains above 30:1. Residual palladium contamination from upstream catalytic hydrogenation steps must be controlled below 5 ppm to prevent catalyst poisoning; the organocatalyst is therefore repurified by sublimation at 110 °C/0.05 mbar prior to use. This transformation has been incorporated into a two-step formal synthesis of a protein kinase Cβ inhibitor intermediate, although multi‑kilogram deployment is hampered by the sensitivity of the catalyst to aerobic oxidation, requiring all process manipulations under purified argon with headspace oxygen monitoring (SST Oxydot sensor, limit 3.0 % vol).